Searchable abstracts of presentations at key conferences in endocrinology

ea0081p25 | Adrenal and Cardiovascular Endocrinology | ECE2022

Fibroblast growth factor 21 contributes to adrenal cortex renewal

Diaz Catalan Daniela , Beyhart Arturo , Mora Mireia , Rodrigo Maite , Boswell Laura , Casals Gregori , Alexandra Hanzu Felicia

Objective: After Cushing Syndrome (CS) is cured, up to 70% of patients develop chronic adrenal insufficiency (AI) and hypothalamus-pituitary-adrenal (HPA) axis dysfunction. A long-term treatment with glucocorticoids (GC) is mandatory to overcome AI. However, this treatment implies non-desired complications. Fibroblast growth factor (FGF21), a key regulator of metabolism, has a bidirectional relationship with GC that bypasses the negative feedback of the HPA axis. In this study...

ea0099p578 | Thyroid | ECE2024

12-month outcome with microwave ablation in benign thyroid nodules

Villa Kelly , Rodrigo Maite , Squarcia Mattia , A Hanzu Felicia , Orois Aida , Claro Maria , Andrea Castillo Arias Karen , Mora Mireia

Most thyroid nodules are benign and majority do not require treatment, except for those large nodules that cause symptoms (compression, hormonal dysfunction and/or esthetic problems). Microwave ablation (MWA) is an attractive therapeutic option because it is minimally invasive, relatively inexpensive, capable of providing coagulative necrosis, and has a short treatment time. In the following, we present the experience of our hospital.Objective: To evalua...